Drug intelligence / Profile preview

senktide

Development stage
Preclinical
Lead developer
Kyoto University
Modality
Small Molecules, Peptides
Administration
Intravenous, Subcutaneous (experimental/animal Use)
01

Overview

**Senktide** is a highly selective synthetic peptide agonist of the neurokinin 3 receptor (NK3R), a G protein-coupled receptor predominantly responsive to neurokinin B. It is derived from the C-terminal hexapeptide of substance P, with the sequence Suc-Asp-Phe-N(Me)Phe-Gly-Leu-Met-NH2 and notable modifications that confer high NK3R selectivity and resistance to enzymatic degradation. Senktide binds and activates NK3R, affecting neuroendocrine regulation by stimulating luteinizing hormone (LH) secretion via hypothalamic-pituitary-gonadal axis activation and is used experimentally to study reproductive function and neuroendocrine mechanisms. It also facilitates episodic-like memory in preclinical models and supports the development of novel therapeutic agents for reproductive and cognitive disorders[2][3][4][5].

Other names
Substance P (6-11), succinyl-asp(6)-Me-phe(8)succinyl-aspartyl(6)-methylphenylalanine(8)Succinyl-6-asp-8-Me-phe-substance P (6-11)106128-89-6
02

Targets

TACR3 (Neurokinin 3 Receptor)

Beyond the preview

Go deeper on senktide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on senktide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call